Web-Based Recorded Sessions.
Empowering clinicians to provide timely care to women living with or at risk of contracting HIV.
The TX/OK AIDS Education & Training Center (TX/OK AETC) is proud to present the 2014 "Women & HIV Web-Based Recorded Sessions." These modules were originally streamed over the internet as Live events on May 16, 2014. These modules have been packaged to continue our 10 year tradition of furthering our goal to “Empower clinicians to provide timely care to women living with or at risk of contracting HIV”.
The Texas/Oklahoma AIDS Education & Training Center (TX/OK AETC) in conjunction with other State and National agencies are working hard to provide health care providers treating women living with or at risk of contracting HIV with up to date medical information. These modules will provide health care providers with current information and tools to provide care to women living with or at risk of contracting HIV.
Overall Learning Objectives
At the end of each session, participants will be able to
- Discuss the link between intimate partner violence and HIV
- Identify two pathways by which intimate partner violence affects the risk of HIV, both globally and nationally
- Describe two drug interactions between HIV and HCV medications
- Describe current recommendations for treatment of STDs in the female patient
- Identify two contraception methods that are effective in preventing transmission of HIV and preventing pregnancy
- Identify two new guidelines for HIV testing of women of reproductive age
- Identify two programs/activities to help confront disparities caused by health determinants
- Discuss two aspects of ART utilization in women that require special consideration due to genomic medicine
- Step 1: Review details on each session such as speakers, topics, brief descriptions, disclosures, & learning objectives in the section entitled, "Session Details" at the bottom of this page. You may participate in as many sessions as desired.
- Step 2: To access each session desired, click-on the corresponding button below in the section entitled, "Registration". Sessions will be taken one-at-a-time. When you are done with one session, you will be routed back to this page to take another..
- Step 3: After you have viewed the session, you will be routed to complete a post-test. To successfully complete the session, you must pass the post-test with a score of 70% or better.
- Step 4: Once you pass the post-test, you will be required to complete a short evaluation on the session.
- Step 5: Once the evaluation has been completed, you will be asked if you would like to request CEs. If you are interested, you will be routed to complete a "CE Request Form." If you say no, you will be routed to Step 6 below.
- Step 6: You will be routed back to this webpage to complete another session.
|Avni Amin, PhD||Technical Officer - Department of Reproductive Health and Research||World Health Organization|
|Frances Ashe-Goins, RN, MPH||Associate Director for Partnership and Programs||U.S. DHHS - Office on Women's Health|
|Teddy Zerai, PharmD, AAHIVP||Clinical Pharmacist HIV Specialist||Harris Health - Thomas Street Clinic|
|Judy Levison, MD, MPH||Associate Professor, Baylor College of Medicine, Joint appointment of the Department of Obstetrics and Gynecology and the Department of Family and Community Medicine||Baylor College of Medicine, Northwest Community Health Center|
|Melanie M. Taylor, MD, MPH||Medical Epidemiologist in the Division of STD Prevention||National center for HIV, Hepatitis, STD & TB Prevention of the Centers for Disease Control & Prevention|
|Jeanne Sheffield, MD||Director - Maternal-Fetal Medicine Fellow Program||University of Texas Southwestern Medical Center|
|RJ Shannon, BS||HIV/AIDS Minority Liaison & Community Engagement Coordinator||Arizona Department of Health Services (ADHS) - HIV Prevention Program|
|Ingrid Floyd, MBA||Executive Director||Iris House|
|Liz Brosnan, BA||Executive Director||Christie's Pace|
|Vanessa Johnson, JD||Managing Director||Ribbon Consulting Group|
Dr. Jain’s relevant financial relationships: Receives grant/research support from Gilead Sciences, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Vertex and AbbVie.
Dr. Jain plans to discuss the off-label/unapproved use of sofosbuvir in combination with simeprevir, and simeprevir in combination with sofosbuvir.
|Mamta Jain, MD||Associate Professor, University of Texas Southwestern||Internal Medicine - UT Southwestern Medical Center|
Clergy/Faith-Based Professional , Dietitian/Nutritionist , Dentist , Health Educator , Mental Health Professional , Nurse , Nurse practitioner , Public Health Professional , Professional , Other Advanced Practice Nurse , Pharmacist , Physician , Physician Assistant , Social WorkerCE Credits:
Medical , Nursing , Pharmacy , Social Work , Certificates of Attendance
This Series is archived and no longer offers ANY Continuing Education Credits